MJA 219 7 2 Oct cover

Issues

Volume 219 Issue 7

2 October 2023

Editor’s choice

2 October 2023 Free

Responding to the challenges of emerging health threats

A key role of a medical journal is to highlight and document emerging health threats, as we know only too well from the role that journals played — and continue to play — during the COVID‐19 pandemic. As the pandemic also demonstrated, despite good knowledge of their pathogenesis generally, infectious diseases remain important causes of morbidity and mortality. This issue of the MJA has two examples that span the range of challenges that infectious diseases pose. Flynn and colleagues discuss the threat to Australian public health of carbapenemase‐producing Enterobacterales (CPE) (doi: 10.5694/mja2.52077). These bacteria are not yet endemic in Australia, but they are elsewhere, and where that is the case there are profound medical and financial implications. Although the highest burden is in hospitals, CPE is also a problem outside of health care settings in residential aged care and in the community. As the authors note, “The potential for CPE transmission in the wider community, particularly among vulnerable older people in aged care facilities, is of concern”. They observe that we probably do not know the burden of disease in Australia: “CPE infection is only notifiable in five of the eight states and territories, and consequently, CPE burden is likely underestimated.” In their closing arguments, they urge action now while the burden of disease is still low, and highlight that an “Australian Centre for Disease Control is ideally placed as a national coordinating body to guide a systematic, evidence‐based and harmonised approach to CPE surveillance and public health action. Australia now has a unique opportunity to take coordinated national action to prevent the spread of CPE.” Challenges from another emerging infectious disease are described in an article by Weerasinghe and colleagues (doi: 10.5694/mja2.52076). Mpox emerged as a disease in May 2022 and information about it is still accumulating, with to date just 154 cases reported in Australia. There is a third‐generation smallpox vaccine being rolled out to high risk groups, but as the authors describe in two individuals, there is a possibility of breakthrough infection. They conclude that “Clinicians should be aware of the possibility of breakthrough modified [monkeypox virus] infection in patients with epidemiological risk factors and a characteristic vesiculopustular rash, despite a history of vaccination.” Finally, turning to a non‐infectious emerging public health threat — vaping. Gardner and colleagues describe the prevalence, patterns of use, and socio‐demographic features of e‐cigarette use by Australian adolescents, collected in a survey of students aged 14–17 years from 70 schools in NSW conducted between 1 July and 31 December 2022 (doi: 10.5694/mja2.52075). The findings are startling: “A total of 1094 of 4204 respondents reported ever having used e‐cigarettes (26.0%; 95% CI, 24.8–27.4%); mean age at first use was 14.0 years (SD, 1.3 years).” This should be compared with the findings noted in their introduction: “A national survey in 2019 found that 10% of 14–17‐year‐old Australians had used e‐cigarettes”. The authors note that because of their methodology, “extrapolation of our findings to all Australian adolescents should be cautious”. However, they conclude that “Our findings indicate that strategies for preventing the uptake and reducing the use of e‐cigarettes by Australian adolescents are needed”. As for emerging infectious diseases, the MJA will continue to report on the public health threat posed by vaping, and the strategies needed to counter it.

Virginia Barbour

Perspectives

Medical education

Infectious diseases 4 September 2023 Lessons from practice Open Access

Breakthrough mpox despite two‐dose vaccination

Clinicians should be aware of the possibility of breakthrough infection in patients with epidemiological risk factors and a characteristic vesiculopustular rash, irrespective of a history of previous vaccination

Madhara N Weerasinghe · Catriona Ooi · George Kotsiou · Vincent J Cornelisse · Arran Painter · Madhara N Weerasinghe · Catriona Ooi · George Kotsiou · Vincent J Cornelisse · Arran Painter

Editorials

Research

Emergency medicine 21 August 2023 Open Access

Hospitalisations and in‐hospital deaths following moderate to severe traumatic brain injury in Australia, 2015–20: a registry data analysis for the Australian Traumatic Brain Injury National Data (ATBIND) project

More effective care strategies are required to reduce the burden of TBI, particularly among younger men

Gerard M O'Reilly · Kate Curtis · Biswadev Mitra · Yesul Kim · Afsana Afroz · Kate Hunter · Courtney Ryder · Delia V Hendrie · Nick Rushworth · Jin Tee · Shane D'Angelo · Emma Solly · Oashe Bhattacharya · Mark C Fitzgerald · Gerard M O'Reilly · Kate Curtis · Biswadev Mitra · Yesul Kim · Afsana Afroz · Kate Hunter · Courtney Ryder · Delia V Hendrie · Nick Rushworth · Jin Tee · Shane D'Angelo · Emma Solly · Oashe Bhattacharya · Mark C Fitzgerald

Study protocol

General medicine 4 September 2023 Open Access

Activating pharmacists to reduce the frequency of medication‐related problems (ACTMed): a stepped wedge cluster randomised trial

The aim is to reduce risks of medicine-related harm, reduce health care costs and improve efficiency, and enhance person-centred care

Jean Spinks · Richard Violette · Douglas IR Boyle · Dennis Petrie · Laura Fanning · Kerry K Hall · Fiona Kelly · Amanda J Wheeler · Robert S Ware · Joshua Byrnes · Esa Chen · Andrew Donald · Nicolette Ellis · Megan DelDot · Lisa Nissen · Jean Spinks · Richard Violette · Douglas IR Boyle · Dennis Petrie · Laura Fanning · Kerry K Hall · Fiona Kelly · Amanda J Wheeler · Robert S Ware · Joshua Byrnes · Esa Chen · Andrew Donald · Nicolette Ellis · Megan DelDot · Lisa Nissen

Research letter

Environmental health 11 September 2023 Open Access

Prevalence, patterns of use, and socio‐demographic features of e‐cigarette use by Australian adolescents: a survey

Strategies for preventing the uptake and reducing the use of e-cigarettes by Australian adolescents are needed

Lauren A Gardner · Siobhan O'Dean · Katrina E Champion · Emily Stockings · Amy‐Leigh Rowe · Maree Teesson · Nicola C Newton · Lauren A Gardner · Siobhan O'Dean · Katrina E Champion · Emily Stockings · Amy‐Leigh Rowe · Maree Teesson · Nicola C Newton

Letters

Next Issue Volume 219 Issue 8

View more
MJA 219 8 16 Oct cover
Editorials 16 October 2023 Free

Diabetes and non‐alcoholic fatty liver disease: a bittersweet symphony

Daniel Clayton‐Chubb · Stuart K Roberts

Perspectives 16 October 2023 Open Access

Dietary management of eosinophilic oesophagitis

Jessica Fitzpatrick · Sarah L Melton · Rebecca E Burgell

Previous Issue Volume 219 Issue 6

View more
MJA 219 6 18 September cover
Editor’s choice 18 September 2023 Free

Supporting an Aboriginal and Torres Strait Voice to Parliament

Virginia Barbour

Perspective 21 August 2023 Open Access

Getting to grips with invasive group A streptococcal infection surveillance in Australia: are we experiencing an epidemic?

Thel K Hla · Jeffrey W Cannon · Asha C Bowen · Rosemary Wyber

Perspectives 24 July 2023 Open Access

Mental health of young Australians: dealing with a public health crisis

Patrick D McGorry · David Coghill · Michael Berk

Medical education 18 September 2023 Lessons from practice Open Access

Saltwater injury: a case of chronic cutaneous Mycobacterium marinum infection

Ruby C Lee · Kennedy Wong · Yolanka Lobo · Heba Jibreal

Subscribe to MJA email alerts

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Terms of Use and our Privacy Policy.

Thanks for Subscribing! Tell us more

Your email updates will use your name.

Good one! Your updates are coming

Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.